Citation Impact
Citing Papers
Halogen bonds in biological molecules
2004 Standout
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Bacteremia Associated With Toothbrushing and Dental Extraction
2008 Standout
Diversity oriented clicking delivers β-substituted alkenyl sulfonyl fluorides as covalent human neutrophil elastase inhibitors
2022 StandoutNobel
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
2000
Year-to-year changes in lung function in individuals with cystic fibrosis
2010
Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease
2007
Extracellular DNA Chelates Cations and Induces Antibiotic Resistance in Pseudomonas aeruginosa Biofilms
2008
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation
2010
Cystic Fibrosis Pulmonary Guidelines
2009
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Management of comorbidities in older patients with cystic fibrosis
2013
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Respiratory Infections With Pseudomonas aeruginosa in Children With Cystic Fibrosis
2002
A Preliminary Study of Aerosolized Recombinant Human Deoxyribonuclease I in the Treatment of Cystic Fibrosis
1992
Cystic fibrosis
2016 Standout
Cystic fibrosis
2003
Interleukin-12 and the regulation of innate resistance and adaptive immunity
2003 Standout
Prosthetic-Joint Infections
2004 Standout
Changing Epidemiology ofPseudomonas aeruginosa Infection in Danish Cystic Fibrosis Patients (1974-1995)
1999
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
2014
Concise review of mechanisms of bacterial adhesion to biomaterial surfaces
1998
Managing Cystic Fibrosis
2011
Effectiveness and tolerability of high‐dose salmeterol in cystic fibrosis
2002
Clinical Use of Ibuprofen Is Associated with Slower FEV 1 Decline in Children with Cystic Fibrosis
2007
Fibrin sheath enhances central venous catheter infection
2002
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis
2014 Standout
Cystic Fibrosis Pulmonary Guidelines
2007
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Defining an exacerbation of pulmonary disease in cystic fibrosis*
2001
New insights into cystic fibrosis-related diabetes in children
2013
Antibiotic resistance of bacteria in biofilms
2001 Standout
Enzymatic Modification of Glycocalyx in the Treatment of Experimental Endocarditis Due to Viridans Streptococci
1987
Standardisation of spirometry
2005 Standout
The evidence base for the efficacy of antibiotic prophylaxis in dental practice
2007
Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus Conference
2003
Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia
2004 StandoutNobel
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis
2015
European Cystic Fibrosis Society Standards of Care: Quality Management in cystic fibrosis
2014
Drug administration by jet nebulization
1998
Guideline for Prevention of Intravascular-Device–Related Infections
1996
Guideline for Prevention of Intravascular-Device-Related Infections
1996
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study
2016
A Comparison of the Availability of Tobramycin for Inhalation From Vented vs Unvented Nebulizers
1998
Staphylococcus epidermidis Extracted Slime Inhibits the Antimicrobial Action of Glycopeptide Antibiotics
1990
Management of Pulmonary Disease in Patients with Cystic Fibrosis
1996
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
The biofilm matrix
2010 Standout
Pulmonary exacerbations in cystic fibrosis
2011
Intestinal mucosal barrier function in health and disease
2009 Standout
Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
1999
Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
2010
Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis
1999
BURKHOLDERIA CEPACIA
1998
Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis
1996
Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis
1994 Standout
Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis
2014
Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins
1991 Standout
Risk factors for rate of decline in FEV1 in adults with cystic fibrosis
2012
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
1989 Standout
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis
2002
A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities
2001
Cystic fibrosis: molecular biology and therapeutic implications
1992 StandoutScience
Prevention of sepsis in total joint arthroplasty
1996
Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients
1999
Infections Related to Central Venous Catheters
1990
Systematic Review of Blood Biomarkers in Cystic Fibrosis Pulmonary Exacerbations
2013
Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator
1995
Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis
2001
Dynamic reciprocity in the wound microenvironment
2011
The role of free radicals in asbestos-induced diseases
1992
Airway Mucus Function and Dysfunction
2010 Standout
Reducing implant-related infections: active release strategies
2006 Standout
Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis
2002
Short‐term effects of three chest physiotherapy regimens in patients hospitalized for pulmonary exacerbations of cystic fibrosis: A cross‐over randomized study
1995
Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis
2011
Infection Control Recommendations for Patients With Cystic Fibrosis: Microbiology, Important Pathogens, and Infection Control Practices to Prevent Patient-to-Patient Transmission
2003
Herpes Zoster
2013 Standout
Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis
2003
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Eosinophils generate brominating oxidants in allergen-induced asthma
2000
Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001 Standout
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU
2006 Standout
Interaction between human polymorphonuclear leucocytes and bacteria released from in-vitro bacterial biofilm models
1994
Guideline for Prevention of Intravascular-Device–Related Infections
1996
Cystic fibrosis
2009
Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project
2002
Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
2011
Chlorhexidine–Alcohol versus Povidone–Iodine for Surgical-Site Antisepsis
2010 Standout
Antifouling Coatings: Recent Developments in the Design of Surfaces That Prevent Fouling by Proteins, Bacteria, and Marine Organisms
2010 Standout
The effects of magnesium, calcium and EDTA on slime production byStaphylococcus epidermidis strains
2003
Antibiotic prophylaxis in infants and young children with cystic fibrosis: A randomized controlled trial
2002
Antibiotic and Anti-Inflammatory Therapies for Cystic Fibrosis
2013
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
2012
Trends in Pulmonary Function in Patients with Cystic Fibrosis Correlate with the Degree of Glucose Intolerance at Baseline
2000
Controlled Trial of Inhaled Budesonide in Patients with Cystic Fibrosis and Chronic Bronchopulmonary Pseudomonas aeruginosa Infection
1997
Spirometry in 3- to 6-Year-Old Children with Cystic Fibrosis
2002
Multiple Combination Bactericidal Antibiotic Testing for Patients with Cystic Fibrosis Infected with Multiresistant Strains of Pseudomonas aeruginosa
2000
Sustained Benefit from Ivacaftor Demonstrated by Combining Clinical Trial and Cystic Fibrosis Patient Registry Data
2015
Bronchopulmonary Disease in Children with Cystic Fibrosis after Early or Delayed Diagnosis
2003
Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis
2014
Sputum Biomarkers of Inflammation and Lung Function Decline in Children with Cystic Fibrosis
2012
Early Respiratory Infection Is Associated with Reduced Spirometry in Children with Cystic Fibrosis
2014
Quantitation of Inflammatory Responses to Bacteria in Young Cystic Fibrosis and Control Patients
1999
Multiple Combination Bactericidal Antibiotic Testing for Patients with Cystic Fibrosis Infected with Burkholderia cepacia
2000
Proteinase 3, a Potent Secretagogue in Airways, Is Present in Cystic Fibrosis Sputum
1999
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis
2003
Overproduction of the CFTR R Domain Leads to Increased Levels of AsialoGM1 and Increased Pseudomonas aeruginosa Binding by Epithelial Cells
1998
Lumacaftor/Ivacaftor in Patients Aged 6–11 Years with Cystic Fibrosis and Homozygous for F508del-CFTR
2017
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
2002 Standout
Changes in Cystic Fibrosis Airway Microbial Community Associated with a Severe Decline in Lung Function
2015
Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
2000 StandoutNature
Coagulase-Negative Staphylococci
1989
Antibiotic Therapy for Chronic Infection of Pseudomonas in the Lung
1993
Defensins Impair Phagocytic Killing by Neutrophils in Biomaterial-Related Infection
1999
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 Standout
Some bacterial parameters influencing the neutrophil oxidative burst response to Pseudomonas aeruginosa biofilms
1992
Preventing Complications of Central Venous Catheterization
2003 Standout
Implications of Rewiring Bacterial Quorum Sensing
2007 StandoutNobel
The role of neutrophil membrane glycoprotein GP-150 in neutrophil adherence to endothelium in vitro
1985
New method for detecting slime production by coagulase negative staphylococci.
1989 Standout
Bacterial Biofilms: A Common Cause of Persistent Infections
1999 StandoutScience
Update on cystic fibrosis-related diabetes
2013
Longevity of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient Registry
2014
Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.
1993 Standout
The chemistry and biology of complement receptors
1984
Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced Macrophages
1993 StandoutScience
Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin
1993
Pharmacokinetics of Tobramycin in Adults with Cystic Fibrosis: Implications for Once-Daily Administration
2000
Taxonomy and Identification of the Burkholderia cepacia Complex
2001
Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission
2003
Role of CFTR in Airway Disease
1999
Biomaterial-Centered Infection: Microbial Adhesion Versus Tissue Integration
1987 StandoutScience
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Potential of preventing Pseudomonas aeruginosa lung infections in cystic fibrosis patients: Experimental studies in animals
1996
Wound Healing: A Cellular Perspective
2018 Standout
The Crisis in Antibiotic Resistance
1992 StandoutScience
Single and Combination Antibiotic Susceptibilities of Planktonic, Adherent, and Biofilm-Grown Pseudomonas aeruginosa Isolates Cultured from Sputa of Adults with Cystic Fibrosis
2002
The Inhibitory Effect of Staphylococcus epidermidis Slime on the Phagocytosis of Murine Peritoneal Macrophages Is Interferon‐Independent
1998
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.
1992
The Halogen Bond
2016 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Structure and function of the leukocyte adhesion molecules CD11/CD18
1990
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Chronic airway colonization byPenicillium emersoniiin a patient with cystic fibrosis
1999
The Calgary Biofilm Device: New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial Biofilms
1999 Standout
Serial Analysis of the Gut and Respiratory Microbiome in Cystic Fibrosis in Infancy: Interaction between Intestinal and Respiratory Tracts and Impact of Nutritional Exposures
2012
Characterization of Tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation
1996
In Vitro and In Vivo Activities of Levofloxacin against Biofilm-Producing Pseudomonas aeruginosa
1998
Works of Warren E. Regelmann being referenced
Clinical significance of the recovery ofAspergillus species from the respiratory secretions of cystic fibrosis patients
1996
Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis
2007
Aerosol Scintigraphy in the Assessment of Therapy for Cystic Fibrosis
1992
Oral glucose tolerance testing in children with cystic fibrosis
2010
Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study
2016
Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations.
1996
Longitudinal assessment of lung function from infancy to childhood in patients with cystic fibrosis
2009
Effect of eosinophil peroxidase on airway epithelial permeability in the guinea pig
1996
A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosis*
2002
PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection.
1997
Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada
1999
Reduction of Sputum Pseudomonas aeruginosa Density by Antibiotics Improves Lung Function in Cystic Fibrosis More than Do Bronchodilators and Chest Physiotherapy Alone
1990
Sputum peroxidase activity correlates with the severity of lung disease in cystic fibrosis
1995
Sputum Desmosine During Hospital Admission for Pulmonary Exacerbation in Cystic Fibrosis
2009
Pulmonary exacerbations in cystic fibrosis
2004
Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function
2007
Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years
1993
Interference with granulocyte function by Staphylococcus epidermidis slime
1986
EFFECT OF EXTRACELLULAR SLIME SUBSTANCE FROM STAPHYLOCOCCUS EPIDERMIDIS ON THE HUMAN CELLULAR IMMUNE RESPONSE
1984
The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis
2008
Impact of Microbiology Practice on Cumulative Prevalence of Respiratory Tract Bacteria in Patients with Cystic Fibrosis
1999
Recurrent infections and delayed separation of the umbilical cord in an infant with abnormal phagocytic cell locomotion and oxidative response during particle phagocytosis
1981
Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study
2013
Oxidative response of human neutrophils, monocytes, and alveolar macrophages induced by unopsonized surface-adherent Staphylococcus aureus
1987
Increased Monocyte Chemiluminescence in Cystic Fibrosis Patients and in their Parents
1986
Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada
1999